Campral

Campral is a brand name for acamprosate calcium which is a medication prescribed to ease the cravings felt by a person who already quit drinking alcohol. It helps in restoring the brain’s chemicals which aims to maintain sobriety by decreasing the physical discomfort and emotional distress felt when having the urge to hit the bottle. Campral was approved by the US Food and Drug Administration (FDA) in 2004, however, had been widely used in Europe for many years prior. This is usually taken three times daily and prescribed 12 months after quitting alcohol. Some side effects included headaches, insomnia, vomiting, loss of appetite, and sometimes, depression.